Our Mission

To improve the Quality of Life of patients around the world through the design, development and delivery of the highest quality innovative therapeutic solutions.

Our Company Shared Values – TEAMWORK

  • teamwork-t


    in each other

  • teamwork-e


    in everything we do

  • teamwork-a


    for actions and results

  • teamwork-m

    Market Driven

    decision making

  • teamwork-w


    to learn and grow

  • teamwork-o

    Open Minded

    to new ideas and change

  • teamwork-r


    for self and others

  • teamwork-k


    of our business and goals

Our Story

You may have heard of Repro Med Systems, Inc. That’s us! Today, we are operating as RMS Medical Products, a leading developer and manufacturer of medical devices and supplies. The company was incorporated in March, 1980 and is now publicly traded . Our stock symbol is REPR.

Worldwide, RMS Medical Products drives healthcare inspiration – in the minds of our patients, our employees, our customers and our shareholders – to give everyone greater freedom for living. We design and manufacture safe, affordable medical devices to make quality healthcare a reality for everyone.

We focus on home and specialty infusion solutions, emphasizing responsive problem-solving for our customers, and careful consideration for the patient experience. Our primary products are the FREEDOM60® and FreedomEdge® DynEQ Infusion Systems, RMS Precision Flow Rate Tubing™, HIgH-Flo Subcutaneous Safety Needle Sets™ and RES-Q-VAC® Hand Held Medical Suction.

We are passionate about helping people with our reliable medical devices made at our HQ in Chester, NY (USA). Our products, as well as product support, are offered worldwide by RMS and through a global network of distributors and service providers.

RMS is excited to expand into new markets with innovative, more technical products. We look forward to productive partnerships with people and companies who share our vision and can help us effectively deliver our value promise to stakeholders in our industry.

Our Latest News & Updates

RMS announces hiring of Eric Bauer as Chief Operating Officer

CHESTER, NY / January 20, 2017 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) (“RMS” or the “Company”) announced today that Mr. Eric Bauer has joined the executive team as Chief Operating Officer, effective January 17, 2017.  Mr. Bauer brings to RMS over 25 years of experience driving operational excellence in growing … Continued

Meet Our Executive Team

  • Andrew Sealfon

    President, Chairman of the Board of Directors, Co-Founder

    Andrew Sealfon, President of the company and Chairman of the Board of Directors, co-founded the company in 1980. Mr. Sealfon is an electrical engineer and inventor and has been granted numerous United States patents. He previously was a member of the Technical Staff of ITT Federal Laboratories, and a member of the research staff of Riverside Research Institute. Mr. Sealfon is a graduate of Lafayette College and continued his graduate studies at Polytechnic Institute of Brooklyn.

  • Dr. Fred Ma


    Dr. Fred Ma, CMO, has over 30 years of broad experience with significant emphasis in neurosurgical practice and pharmaceuticals/device industries. Dr. Ma is a result-oriented executive with a track record of success for product research and developments in all phases towards final approvals/clearances, commercialization and driving business growth. He is well-recognized and respected within the regulatory agencies, professional organizations and industries in the United States and globally. Dr. Ma has directly designed and supervised over 100 product developments, 600 clinical trials and many successful regulatory approvals/clearances in the US and rest of the world.

  • Karen Fisher


    Karen Fisher, CFO, has more than 19 years of financial experience at a variety of industries, most recently serving as Assistant Controller, Senior Manager for Armored Autogroup, Inc., a worldwide consumer products company, from February 2012 to January 2015. Before joining Armored Autogroup, Inc., she spent seven years at Gilman Ciocia, Inc., where she served in a variety of financial roles, including Chief Accounting Officer and Treasurer, and, earlier, as Controller. Before Gilman Ciocia, Inc., Ms. Fisher held multiple financial management roles at The New York Times Company and Thomson Financial. Ms. Fisher is a Certified Public Accountant and a graduate of Arizona State University with a BS in accounting.

  • Manuel Marques

    VP Operations

    Manuel (Manny) Marques, VP Operations, has an engineering background in FDA Class II & III medical devices. He has a proven history of effectively transferring new products from R&D into manufacturing, while also reducing operating and manufacturing costs of existing products. Mr. Marques is a champion at enhancing operational management via implementation of Lean 6-Sigma Manufacturing techniques.  Mr. Marques holds two US Patents for cardiovascular medical devices.

  • Chatarina Soderman

    VP Product Marketing, Intl Dir of Marketing & Clinical Advisor

    Chatarina Soderman, VP Product Marketing, has extensive management experiences within marketing, business, sales and product management, including new product development in the Life Science and Medical Device industries. In addition to her strong business background, Ms. Soderman is an RN. She continues to work with major pharmaceutical companies conducting trials and sharing her findings with the industry.

  • Dr. Sabino Loiodice

    Director of International Marketing and Sales

    Dr. Sabino Loiodice, a native of Italy, holds an undergraduate degree from Binghamton University, as well as an MBA and Doctorate from universities in Nevada. After returning to Italy to serve in the military, he began working with commercial divisions of U.S. Multi-International corporations.  His 20+ years of experience includes International Sales/Marketing Management in capital equipment and medical devices as applied to orthopedics, neurosurgery/neurology, spine surgery, radiology (conventional & digital), hand surgery, gynecology and clinical chemistry.  In 2013, Dr. Loiodice was honored to be appointed Cavaliere by Italy’s President, pursuant to the development of an advanced Class III medical device for prevention of post-surgical fibrosis in tendon/nerve surgery.

Investor Relations